Tango Therapeutics annual net debt
2020
2021
2022
2023
2024
2025
Tango Therapeutics Net Debt Growth & History (TNGX)
Tango Therapeutics's net debt was −$78.7M for fiscal 2025.
View full Tango Therapeutics company overviewTango Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$78.7M | −$45.7M | — |
| 2024 | 2024-12-31 | −$33.0M | −$3.1M | — |
| 2023 | 2023-12-31 | −$29.9M | −$11.1M | — |
| 2022 | 2022-12-31 | −$18.8M | $122.4M | — |
| 2021 | 2021-12-31 | −$141.2M | −$120.7M | — |
| 2020 | 2020-12-31 | −$20.5M | — | — |
Tango Therapeutics quarterly net debt
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$313.6M | −$309.3M | — |
| Q1 2026 | 2026-03-31 | −$125.0M | −$103.6M | — |
| Q4 2025 | 2025-12-31 | −$78.7M | −$45.7M | — |
| Q3 2025 | 2025-09-30 | −$23.6M | −$8.1M | — |
| Q2 2025 | 2025-06-30 | −$4.3M | $9.5M | — |
| Q1 2025 | 2025-03-31 | −$21.5M | $1.4M | — |
| Q4 2024 | 2024-12-31 | −$33.0M | −$3.1M | — |
| Q3 2024 | 2024-09-30 | −$15.5M | $3.5M | — |
| Q2 2024 | 2024-06-30 | −$13.7M | $12.4M | — |
| Q1 2024 | 2024-03-31 | −$22.9M | −$7.0M | — |
| Q4 2023 | 2023-12-31 | −$29.9M | −$11.1M | — |
| Q3 2023 | 2023-09-30 | −$19.0M | $40.6M | — |
| Q2 2023 | 2023-06-30 | −$26.2M | $77.8M | — |
| Q1 2023 | 2023-03-31 | −$15.9M | $83.0M | — |
| Q4 2022 | 2022-12-31 | −$18.8M | $122.4M | — |
| Q3 2022 | 2022-09-30 | −$59.6M | $138.2M | — |
| Q2 2022 | 2022-06-30 | −$104.0M | — | — |
| Q1 2022 | 2022-03-31 | −$98.8M | — | — |
| Q4 2021 | 2021-12-31 | −$141.2M | −$120.7M | — |
| Q3 2021 | 2021-09-30 | −$197.8M | — | — |
| Q4 2020 | 2020-12-31 | −$20.5M | — | — |
Tango Therapeutics net debt trends
Over the last five fiscal years, Tango Therapeutics's net debt decreased from −$20.5M to −$78.7M, a change of −$58.2M. The latest reported quarter, Q2 2026, shows −$313.6M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tango Therapeutics source filings ↗